Janet Freeman-Daily, MS, Eng, is a retired aerospace systems engineer, freelance writer, speaker, and research advocate. She was diagnosed with metastatic non-small cell lung cancer in 2011, learned about biomarker testing and clinical trials from online patient communities, joined a trial for a ROS1+ targeted therapy, and has had no sign of cancer on scans since January 2013. Her focus is now on translating the experience and science of cancer for others. She writes an award-winning blog, cofounded and manages The ROS1ders, co-developed and staffs the IASLC STARS program, and works as a cancer research advocate at the national and international level.